Katholieke Universiteit Leuven competitive analysis

Explore Katholieke Universiteit Leuven's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Aug 27, 2026
Patent NumberPublication DateTitleTotal Oppositions
Mar 17, 2021Fenfluramine For Use In The Treatment Of Dravet Syndrome3
Feb 26, 2020High-Throughput Genotyping By Sequencing Low Amounts Of Genetic Material1
Mar 7, 2018Fenfluramine For Use In The Treatment Of Dravet Syndrome1

Latest PTAB cases involving Katholieke Universiteit Leuven

Discover the latest PTAB cases involving Katholieke Universiteit Leuven, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Katholieke Universiteit Leuven with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Aug 27, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
KATHOLIEKE UNIVERSITEIT LEUVEN - 2 - -
TEVA PHARMACEUTICAL INDUSTRIES LTD2094 - -